Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague–Dawley rats: Dose–response, and biochemical and pharamacokinetic parameters
- 29 August 2005
- journal article
- Published by Elsevier in Toxicology
- Vol. 215 (1-2) , 149-169
- https://doi.org/10.1016/j.tox.2005.07.019
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Prenatal window of susceptibility to perfluorooctane sulfonate‐induced neonatal mortality in the Sprague‐Dawley ratBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Serum Thyroxine Binding Capacity-Dependent Bias in an Automated Free Thyroxine AssayJournal of Immunoassay, 1999
- Euthyroid Sick Syndrome: Is It a Misnomer?Journal of Clinical Endocrinology & Metabolism, 1997
- HMG‐CoA reductase mRNA in the post‐implantation rat embryo studied by in situ hybridizationTeratology, 1993
- The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Dietary regulation of maternal and fetal cholesterol metabolism in the guinea pigBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Preclinical evaluation of lovastatinThe American Journal of Cardiology, 1988
- Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductaseTeratology, 1983
- Rat liver glycogen metabolism in the perinatal periodBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Thyroxine and palatal development in rat embryosDevelopmental Biology, 1975